Taiwan · Delayed Price · Currency is TWD GeneFerm Biotechnology Statistics
Total Valuation
TPEX:1796 has a market cap or net worth of TWD 1.14 billion. The enterprise value is 1.19 billion.
| Market Cap | 1.14B |
| Enterprise Value | 1.19B |
Important Dates
The next estimated earnings date is Tuesday, November 10, 2026.
| Earnings Date | Nov 10, 2026 |
| Ex-Dividend Date | Jul 14, 2026 |
Share Statistics
TPEX:1796 has 41.46 million shares outstanding. The number of shares has decreased by -2.12% in one year.
| Current Share Class | 41.46M |
| Shares Outstanding | 41.46M |
| Shares Change (YoY) | -2.12% |
| Shares Change (QoQ) | -0.02% |
| Owned by Insiders (%) | 9.52% |
| Owned by Institutions (%) | n/a |
| Float | 20.67M |
Valuation Ratios
The trailing PE ratio is 153.52.
| PE Ratio | 153.52 |
| Forward PE | n/a |
| PS Ratio | 1.71 |
| PB Ratio | 1.46 |
| P/TBV Ratio | 1.47 |
| P/FCF Ratio | 72.16 |
| P/OCF Ratio | 20.88 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.50, with an EV/FCF ratio of 75.44.
| EV / Earnings | 164.08 |
| EV / Sales | 1.78 |
| EV / EBITDA | 15.50 |
| EV / EBIT | 147.64 |
| EV / FCF | 75.44 |
Financial Position
The company has a current ratio of 3.63, with a Debt / Equity ratio of 0.35.
| Current Ratio | 3.63 |
| Quick Ratio | 2.16 |
| Debt / Equity | 0.35 |
| Debt / EBITDA | 3.57 |
| Debt / FCF | 17.37 |
| Interest Coverage | 1.32 |
Financial Efficiency
Return on equity (ROE) is 0.92% and return on invested capital (ROIC) is 0.82%.
| Return on Equity (ROE) | 0.92% |
| Return on Assets (ROA) | 0.41% |
| Return on Invested Capital (ROIC) | 0.82% |
| Return on Capital Employed (ROCE) | 0.76% |
| Weighted Average Cost of Capital (WACC) | 4.37% |
| Revenue Per Employee | 4.65M |
| Profits Per Employee | 50,535 |
| Employee Count | 144 |
| Asset Turnover | 0.54 |
| Inventory Turnover | 2.62 |
Taxes
In the past 12 months, TPEX:1796 has paid 1.46 million in taxes.
| Income Tax | 1.46M |
| Effective Tax Rate | 16.71% |
Stock Price Statistics
The stock price has decreased by -45.98% in the last 52 weeks. The beta is 0.13, so TPEX:1796's price volatility has been lower than the market average.
| Beta (5Y) | 0.13 |
| 52-Week Price Change | -45.98% |
| 50-Day Moving Average | 28.97 |
| 200-Day Moving Average | 35.37 |
| Relative Strength Index (RSI) | 36.32 |
| Average Volume (20 Days) | 29,272 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:1796 had revenue of TWD 669.49 million and earned 7.28 million in profits. Earnings per share was 0.18.
| Revenue | 669.49M |
| Gross Profit | 161.75M |
| Operating Income | 8.09M |
| Pretax Income | 8.74M |
| Net Income | 7.28M |
| EBITDA | 75.26M |
| EBIT | 8.09M |
| Earnings Per Share (EPS) | 0.18 |
Balance Sheet
The company has 223.23 million in cash and 275.01 million in debt, with a net cash position of -51.77 million or -1.25 per share.
| Cash & Cash Equivalents | 223.23M |
| Total Debt | 275.01M |
| Net Cash | -51.77M |
| Net Cash Per Share | -1.25 |
| Equity (Book Value) | 779.96M |
| Book Value Per Share | 18.82 |
| Working Capital | 387.92M |
Cash Flow
In the last 12 months, operating cash flow was 54.71 million and capital expenditures -38.88 million, giving a free cash flow of 15.83 million.
| Operating Cash Flow | 54.71M |
| Capital Expenditures | -38.88M |
| Depreciation & Amortization | 67.17M |
| Net Borrowing | -40.11M |
| Free Cash Flow | 15.83M |
| FCF Per Share | 0.38 |
Margins
Gross margin is 24.16%, with operating and profit margins of 1.21% and 1.09%.
| Gross Margin | 24.16% |
| Operating Margin | 1.21% |
| Pretax Margin | 1.31% |
| Profit Margin | 1.09% |
| EBITDA Margin | 11.24% |
| EBIT Margin | 1.21% |
| FCF Margin | 2.36% |
Dividends & Yields
This stock pays an annual dividend of 0.70, which amounts to a dividend yield of 2.54%.
| Dividend Per Share | 0.70 |
| Dividend Yield | 2.54% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 3 |
| Payout Ratio | 398.82% |
| FCF Payout Ratio | 37.04% |
| Buyback Yield | 2.12% |
| Shareholder Yield | 4.66% |
| Earnings Yield | 0.65% |
| FCF Yield | 1.39% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |